Longitudinal in vivo monitoring of axonal degeneration after brain injury is a research paper published in Cell Reports Methods (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of General Medical Sciences
Grant: RM1 GM142002
U.S. Department of Veterans Affairs
Grant: I01BX005976
BrightFocus Foundation
Grant: A2019551F
U.S. Department of Defense
Grant: AZ210092
U.S. Department of Defense
Grant: W81XWH-22-1-0129
NIH
Grant: RO1AG066707
NIH
Grant: 1 U01 AG073323
NIA NIH HHS
Grant: R01 AG066707
NIA NIH HHS
Grant: T32 AG071474
NIA NIH HHS
Grant: P30 AG062428
NIA NIH HHS
Grant: U01 AG073323
National Institutes of Health
Grant: 1F32GM013039-01
MOLECULAR ANALYSIS OF THE YEAST HEAT SHOCK TRANSCRIPTION
National Institutes of Health
Grant: 1I01BX005976-01A1
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
National Institutes of Health
Grant: 1T32AG071474-01
The Alzheimer's Disease Translational Data Science Training Program
National Institutes of Health
Grant: 5RM1GM142002-05
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration
National Institutes of Health
Grant: 5U01AG073323-05
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
National Institutes of Health
Grant: 5R01AG066707-04
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
Howard Hughes Medical Institute
Brockman Foundation
Case Western Reserve University
National Institute on Aging
FWCI
2.50
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 4 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Additional file 4 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Additional file 3 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Additional file 3 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Additional file 2 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Additional file 2 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Additional file 1 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
Additional file 1 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury